Biomedical Engineering Reference
In-Depth Information
[202] Jones AL , Kellaway IW , Taylor G . Pulmonary absorption of aerosolised insulin in the
rabbit . J Pharm Pharmacol 1988 ; 40 : 92 .
[203] Liu F , Shao Z , Kildsig D , Mitra AK . Pulmonary delivery of free and liposomal insulin .
Pharm Res 1993 ; 10 : 228 - 32 .
[204] Kawashima Y , Yamamoto H , Takeuchi H , Fujioka S , Hino T . Pulmonary delivery of
insulin with nebulized
DL
-lactide/glycolide copolymer (PLGA) nanospheres to prolong
hypoglycemic effect . J Control Release
1999 ; 62 : 279 - 87 .
[205] Kumar TM , Misra A . Influence of absorption promoters on pulmonary insulin bioacti-
vity . AAPS Pharm Sci Technol Today 2003 ; 4 : 1 - 12 .
[206] Rave K , Bott S , Heinemann L , Sha S , Becker R , Heise T . Time action profile of inhaled
insulin in comparison with subcutaneously injected insulin LISPRO and regular com-
mon insulin . Diabetes Care 2005 ; 28 : 1077 - 82 .
[207] Owens
DR .
New
horizons - alternative
routes
for
insulin
therapy .
Nat
Rev
Drug
Discovery 2002 ; 1 : 529 - 40 .
[208] White S , Bennett DB , Cheu S , Conley PW . Exubera: pharmaceutical development of
novel product for pulmonary delivery of insulin . Diabetes Technol Ther 2005 ; 7 : 896 - 906 .
[209] Hollander PA . Evolution of a pulmonary insulin delivery system (
Exubera
) for patients
with diabetes . Med Gen Med 2007 ; 9 : 45 .
[210] Adjei AL , Carrigan PJ . Pulmonary bioavailability of LH -RH analogs: some biopharma-
ceutical guidelines . J Biopharm Sci 1992 ; 3 : 247 - 54 .
[211] Marshall JC , Odell WD . Preparation of biologically active [
125
I] - LHRH suitable for
membrane binding studies . Proc Soc Exp Biol Med 1975 ; 149 : 351 - 5 .
[212] Groth T , Rosberg S , Albertsson - Wikland K . Estimation of growth hormone secretory
patterns in children with use of a numerical deconvolution technique: experimental
design with use of computer simulation . Horm Res 1994 ; 42 : 245 - 52 .
[213] Albertsson - Wikland K , Westphal O , Westgren U . Daily subcutaneous administration of
human growth hormone in growth hormone deficient children . Acta Paediatr Scand 1986 ;
7 5 : 8 9 - 9 7 .
[214] Colthorpe P , Farr SJ , Smith IJ . The influence of regional deposition on the pharmacokinet-
ics of pulmonary-delivered human growth hormone in rabbits . Pharm Res 1995 ; 12 : 356 - 9 .
[215] Patton JS , McCabe JG , Hansen SE , Daugherty AL . Absorption of human growth hor-
mone from the rat lung . Biotechnol Ther 1990 ; 1 : 213 - 28 .
[216] Bowers CY , Momany F , Reynolds GA , Hong A . On the
in vitro
and
in vivo
activity of a
new synthetic hexapeptide that acts on the pituitary to specifically release growth hor-
mone . Endocrinology 1984 ; 114 : 1537 - 45 .
[217] Momany FA , Bowers CY , Reynolds CA . Design, synthesis, and biological activity of
peptides which release growth hormone
in vitro
. Endocrinology 1981 ; 108 : 31 - 9 .
[218] Bowers CY , Alster DK , Frentz JM . The growth hormone -releasing activity of a syn-
thetic hexapeptide in normal men and short statured children after oral administration .
J Clin Endocrinol Metab 1992 ; 74 : 292 - 8 .
[219] Ilson BE , Jorkasky DK , Curnow RT , Stote RM . Effect of a new synthetic hexapep-
tide to selectively stimulate growth hormone release in healthy human subjects . J Clin
Endocrinol Metab 1989 ; 69 : 212 - 14 .
[220] Hayashi S , Okimura Y , Yagi H , Uchiyama T , Takeshima Y ,
Shakutsui S , et al . Intranasal
administration of His-D-Trp-Ala-Trp-D-Phe-LysNH2 (growth hormone releasing pep-
tide) increased plasma growth hormone and insulin-like growth factor-1 levels in nor-
mal men . Endocrinol Jpn 1991 ; 38 : 15 - 21 .
[221] Smith PL , Yeulet SE , Citerone DR , Drake F , Cook K , Wall DA , et al . SK & F 110679:
comparison of absorption following oral or respiratory administration . J Control Release
1994 ; 28 : 67 - 77 .
Search WWH ::
Custom Search